We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
-17.26%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+535.77%
AUM
$3.29B
AUM Growth
-$744M
Cap. Flow
+$126M
Cap. Flow %
3.81%
Top 10 Hldgs %
18.14%
Holding
1,378
New
105
Increased
487
Reduced
524
Closed
187

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$24.5M
2
MSFT icon
Microsoft
MSFT
+$21.4M
3
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$11.4M
4
JPM icon
JPMorgan Chase
JPM
+$10.4M
5
AMZN icon
Amazon
AMZN
+$6.31M

Top Sells

Rank Stock Value
1
TGT icon
Target
TGT
+$6.95M
2
NKE icon
Nike
NKE
+$5.91M
3
UNH icon
UnitedHealth
UNH
+$5.38M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$5.36M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$4.93M

Sector Composition

Rank Sector Weight
1 Technology 16.51%
2 Healthcare 13.38%
3 Financials 10.48%
4 Consumer Discretionary 8.32%
5 Communication Services 7.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FPL
1151
DELISTED
FIRST TRUST NEW OPPORTUNITIES MLP & ENERGY FUND
FPL
$59K ﹤0.01%
+16,402
New +$125K
ANGI icon
1152
Angi Inc
ANGI
$182M
$54K ﹤0.01%
1,020
-390
-28% -$29K
RIG icon
1153
Transocean
RIG
$6.49B
$54K ﹤0.01%
46,795
-23,624
-34% -$92.2K
ATAXZ
1154
DELISTED
AMERICA FIRST TAX EXEMT INV LP
ATAXZ
$54K ﹤0.01%
+10,257
New +$54K
ATYR
1155
aTyr Pharma
ATYR
$52.4M
$53K ﹤0.01%
+18,941
New +$81.8K
ENLC
1156
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$52K ﹤0.01%
47,030
– –
CBUS icon
1157
Cibus
CBUS
$145M
$47K ﹤0.01%
+284
New +$78.9K
TXMD icon
1158
TherapeuticsMD
TXMD
$24M
$46K ﹤0.01%
857
-115
-12% -$11.4K
PDLI
1159
DELISTED
PDL BioPharma, Inc.
PDLI
$43K ﹤0.01%
15,188
– –
VNRX icon
1160
VolitionRx Ltd
VNRX
$8.61M
$40K ﹤0.01%
648
– –
AMRS
1161
DELISTED
Amyris Inc.
AMRS
$36K ﹤0.01%
14,000
– –
GOGO icon
1162
Gogo Inc
GOGO
$392M
$35K ﹤0.01%
16,300
-4,350
-21% -$18.6K
HIMX
1163
Himax Technologies
HIMX
$2.61B
$33K ﹤0.01%
12,240
– –
HLX icon
1164
Helix Energy Solutions
HLX
$1.5B
$33K ﹤0.01%
20,000
– –
CX icon
1165
Cemex
CX
$16.1B
$32K ﹤0.01%
15,240
– –
ADMA icon
1166
ADMA Biologics
ADMA
$2.22B
$31K ﹤0.01%
10,836
+810
+8% +$2.8K
KOPN icon
1167
Kopin
KOPN
$964M
$31K ﹤0.01%
87,500
+7,000
+9% +$2.67K
NML
1168
Neuberger Energy Infrastructure and Income Fund Inc
NML
$598M
$31K ﹤0.01%
+16,573
New +$89.2K
SONM icon
1169
DNA X Inc
SONM
$5.36M
$30K ﹤0.01%
24
-47
-66% -$225K
ATHX
1170
DELISTED
Athersys, Inc. Common Stock
ATHX
$30K ﹤0.01%
400
– –
CTR
1171
DELISTED
ClearBridge MLP and Midstream Total Return Fund Inc.
CTR
$26K ﹤0.01%
3,832
+686
+22% +$22.1K
VBIV
1172
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$25K ﹤0.01%
873
+343
+65% +$13.3K
OPK icon
1173
Opko Health
OPK
$1.04B
$24K ﹤0.01%
17,700
+7,000
+65% +$11K
NTG
1174
DELISTED
Tortoise Midstream Energy Fund, Inc. Common Stock
NTG
$24K ﹤0.01%
2,804
-5,529
-66% -$435K
SIEN
1175
DELISTED
Sientra, Inc.
SIEN
$20K ﹤0.01%
+1,000
New +$52.2K
45 46
47
48 49

Similar funds

AC
Allstate Corporation Northbrook, Illinois $9.35B AUM 16.13% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.34B AUM 12.2% 1-Year Est. Return
WPL
WINDACRE PARTNERSHIP LLC Houston, Texas $9.34B AUM 17.41% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $9.32B AUM 33.19% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return

Oppenheimer & Co's Q1 2020 Portfolio in Review

As of Q1 2020, Oppenheimer & Co held 1,378 positions worth $3.29B, down 18% from $4.04B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Oppenheimer & Co deployed $126M of net new capital in Q1 2020, opening 105 new positions and adding to 487 existing holdings. Its largest new stake was Hasbro: 50,954 shares worth $3.65M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Target, an estimated $6.95M trimmed.

  • Oppenheimer & Co's largest Q1 2020 buy was Hasbro: 50,954 shares worth $3.65M.
  • Oppenheimer & Co added most to Invesco QQQ Trust in Q1 2020, an estimated $24.5M increase.
  • Oppenheimer & Co's biggest Q1 2020 reduction was Target, cutting an estimated $6.95M.
  • Oppenheimer & Co fully exited Campbell Soup in Q1 2020, selling an estimated $3.76M.
  • Oppenheimer & Co's ten largest holdings make up 18% of its $3.29B portfolio in Q1 2020.
  • Oppenheimer & Co opened 105 new positions and closed 187 in Q1 2020.
  • Oppenheimer & Co's portfolio value fell 18% quarter-over-quarter to $3.29B.

Based on Oppenheimer & Co's 13F filing for Q1 2020, filed 8 May 2020.